<p>(A) HeLa cells were treated with cisplatin for 24 h. Total RNA was extracted for reverse-transcription PCR with ARNT and GAPDH primers. (B) HeLa cells were treated with 10 µM MG132 or 1 µM lactacystin for 4 h followed by cisplatin for 36 h. Expression of ARNT and actin were analyzed by Western blotting analysis using anti-ARNT and anti-actin antibodies. (C) HeLa and HeLaR cells were treated with various concentrations of taxol and doxorubicin for 24 h. Expressions of ARNT and actin were detected by Western blotting analysis using anti-ARNT and anti-actin antibodies. (D) After 30 µM cisplatin treatment of HeLa and HeLa R cells, apoptotic DNA fragmentation was determined as described in "<a href="http://www.plosone.org/article/info:doi/10....
<p>(A) The A2058 cells treated with CT16 specific or control siRNA were subjected to Cell titer 96 p...
<p>ECC-1 cells (<b>A and B</b>) and MCF7 cells (<b>C and D</b>) were transfected with either scrambl...
<p>(A) Effects of RIPK3 knockdown were determined using western blot analysis, β-Actin as a loading ...
<p>HONE-1 cells were transfected with 50 nM siARNT or 50 nM stealth RNAi negative control (SC) for 2...
WOS: 000505071500002Objective: Cervical cancer is one of the most tumors seen in womans and second l...
<p>(A) RNA was extracted using an RNA isolation kit for microarray analysis after cisplatin treatmen...
<p><b>(A)</b> A549cisR cells were treated for 24 hours with 25 μM cisplatin prior to transfection wi...
<p>, A549 cells were treated with vehicle control, cisplatin alone, vorinostat alone, or cisplatin a...
Background: Unique characteristics of tumor microenvironments can be used as targets of cancer thera...
BACKGROUND: Unique characteristics of tumor microenvironments can be used as targets of cancer thera...
<p>(A) KYSE140 cells were treated with 10 µM cisplatin for 6, 12, or 24 h, and the RIPK3 mRNA level ...
<p><b>(A, B)</b> A549Pt and A549cisR cells were plated in 24-well plates and grown for 24 hours, the...
<p>A549Pt and A549cisR cells were treated for 48 hours with 5 μM and 5 μM or 25 μM cisplatin (cisPt)...
Unique characteristics of tumor microenvironments can be used as targets of cancer therapy. The aryl...
<p><b>A)</b> HCT116 clones D6 and D7 were treated with 15 µM cisplatin (CP) for 24 or 48 hrs, follow...
<p>(A) The A2058 cells treated with CT16 specific or control siRNA were subjected to Cell titer 96 p...
<p>ECC-1 cells (<b>A and B</b>) and MCF7 cells (<b>C and D</b>) were transfected with either scrambl...
<p>(A) Effects of RIPK3 knockdown were determined using western blot analysis, β-Actin as a loading ...
<p>HONE-1 cells were transfected with 50 nM siARNT or 50 nM stealth RNAi negative control (SC) for 2...
WOS: 000505071500002Objective: Cervical cancer is one of the most tumors seen in womans and second l...
<p>(A) RNA was extracted using an RNA isolation kit for microarray analysis after cisplatin treatmen...
<p><b>(A)</b> A549cisR cells were treated for 24 hours with 25 μM cisplatin prior to transfection wi...
<p>, A549 cells were treated with vehicle control, cisplatin alone, vorinostat alone, or cisplatin a...
Background: Unique characteristics of tumor microenvironments can be used as targets of cancer thera...
BACKGROUND: Unique characteristics of tumor microenvironments can be used as targets of cancer thera...
<p>(A) KYSE140 cells were treated with 10 µM cisplatin for 6, 12, or 24 h, and the RIPK3 mRNA level ...
<p><b>(A, B)</b> A549Pt and A549cisR cells were plated in 24-well plates and grown for 24 hours, the...
<p>A549Pt and A549cisR cells were treated for 48 hours with 5 μM and 5 μM or 25 μM cisplatin (cisPt)...
Unique characteristics of tumor microenvironments can be used as targets of cancer therapy. The aryl...
<p><b>A)</b> HCT116 clones D6 and D7 were treated with 15 µM cisplatin (CP) for 24 or 48 hrs, follow...
<p>(A) The A2058 cells treated with CT16 specific or control siRNA were subjected to Cell titer 96 p...
<p>ECC-1 cells (<b>A and B</b>) and MCF7 cells (<b>C and D</b>) were transfected with either scrambl...
<p>(A) Effects of RIPK3 knockdown were determined using western blot analysis, β-Actin as a loading ...